Showing results (111-120 of 167) with videos related to
Sort By:
Pageof 17
Cancers|March 6, 2021
Identification and Validation of ERK5 as a DNA Damage Modulating Drug Target in GlioblastomaNatasha Carmell, Ola Rominiyi, Katie N Myers, et al.European Urology|October 9, 2018
Efficacy of Radium-223 in Bone-metastatic Castration-resistant Prostate Cancer with and Without Homologous Repair Gene DefectsPedro Isaacsson Velho, Fahad Qazi, Sayeedul Hassan, et al.International Journal of Surgical Pathology|April 9, 2013
Comparison of biochemical recurrence-free survival between periprostatic and pelvic lymph node metastases of prostate cancerNilda González-Roibón, Jeong S Han, Stephen Lee, et al.JAMA Network Open|January 16, 2019
Association of a Simulated Institutional Gender Equity Initiative With Gender-Based Disparities in Medical School Faculty Salaries and PromotionsAvani D Rao, Sarah E Nicholas, Bartlomiej Kachniarz, et al.Cell Reports|August 30, 2016
MRNIP/C5orf45 Interacts with the MRN Complex and Contributes to the DNA Damage ResponseChristopher J Staples, Giancarlo Barone, Katie N Myers, et al.Oncotarget|July 24, 2018
The relationship of CDK18 expression in breast cancer to clinicopathological parameters and therapeutic responseGiancarlo Barone, Arvind Arora, Anil Ganesh, et al.Nucleic Acids Research|July 7, 2016
Human CDK18 promotes replication stress signaling and genome stabilityGiancarlo Barone, Christopher J Staples, Anil Ganesh, et al.International Journal of Radiation Oncology, Biology, Physics|April 10, 2007
Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapyMary Feng, Alexandra L Hanlon, Thomas M Pisansky, et al.The Prostate|October 9, 2015
GSTP1 Loss results in accumulation of oxidative DNA base damage and promotes prostate cancer cell survival following exposure to protracted oxidative stressOmar Y Mian, Mohamed H Khattab, Mohammad Hedayati, et al.Cancer Research|November 1, 2008
DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneitySrinivasan Yegnasubramanian, Michael C Haffner, Yonggang Zhang, et al.Pageof 17